Tag Archives: BLRX

Best Heal Care Stocks To Own Right Now

Leave a reply

Thermo Fisher Scientific (NYSE:TMO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Thermo Fisher ended the first quarter on a promising note with adjusted earnings and revenues surpassing the consensus mark. We are encouraged by the company’s solid international performance on strong growth in the emerging markets of China, South Korea and India. Also, a series of product launches along with major progress in precision medicine initiatives aided Thermo Fisher’s performance. Moreover, the Patheon buyout has substantially adding an impetus to the company’s value proposition for biopharma customers. Notably, it has already started to prove accretive to Thermo Fisher’s Laboratory Products and Services segment. The company has outperformed its industry in the past year. On the flip side, in the reported quarter, Thermo Fisher’s business segments were impacted by unfavorable business mix. Also, competitive headwinds and rising operating costs continue to pose a threat.”

Best Heal Care Stocks To Own Right Now: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Eric Volkman]

    The problem is that owning and maintaining rail assets is ferociously expensive, and transporting humans isn’t as lucrative as hauling cargo. The major and successful publicly traded rail companies — Canadian National Railway (NYSE:CNI) and CSX (NASDAQ:CSX), to name two — all concentrate on moving stuff rather than people.

  • [By Neha Chamaria]

    Canadian National Railway (NYSE:CNI) is facing a unique problem: too much demand that it can’t seem to handle. Severe capacity shortages and delay in deliveries last quarter proved costly for the railroad, as evidenced by its just released first-quarter earnings report.

  • [By Shane Hupp]

    Shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) have been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $91.71.

Best Heal Care Stocks To Own Right Now: Churchill Downs, Incorporated(CHDN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BNP Paribas Arbitrage SA decreased its position in shares of Churchill Downs, Inc. (NASDAQ:CHDN) by 64.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,334 shares of the company’s stock after selling 2,396 shares during the period. BNP Paribas Arbitrage SA’s holdings in Churchill Downs were worth $396,000 at the end of the most recent reporting period.

  • [By ]

    More than 157,000 people attended the 2018 Kentucky Derby at Churchill Downs (Nasdaq: CHDN) to watch Triple Crown winner Justify. The iconic 143-year-old facility generates $900 million in annual revenue, with gamblers placing $11 billion in horse wagers industrywide each year — not counting what they spend away from the pari-mutuel betting windows.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,

Best Heal Care Stocks To Own Right Now: Community Trust Bancorp, Inc.(CTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Community Trust Bancorp, Inc. (NASDAQ:CTBI) reached a new 52-week high and low on Wednesday . The stock traded as low as $52.30 and last traded at $52.10, with a volume of 1141 shares trading hands. The stock had previously closed at $52.05.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Own Right Now: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on BIOLINERX Ltd/S (BLRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    BioLine Rx Ltd. (Nasdaq: BLRX) has the cheapest share price of the three stocks on this list.

    Currently trading at $1.16 per share, this Israel-based company focuses on developing therapeutics for a range of medical needs, including serious cardiac issues, liver fibrosis, pain management, cancer, and inflammatory bowel disease.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BIOLINERX Ltd/S (BLRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)

Best Heal Care Stocks To Own Right Now: B Communications Ltd.(BCOM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the telecommunication services shares climbed 0.69 percent. Meanwhile, top gainers in the sector included B Communications Ltd (NASDAQ: BCOM), up 5 percent, and China Unicom (Hong Kong) Limited (NYSE: CHU), up 3 percent.

Best Heal Care Stocks To Own Right Now: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    Sangamo Therapeutics (NASDAQ:SGMO) closed down 10.5% while bluebird bio (NASDAQ:BLUE) slipped 4.8% after competitor Global Blood Therapeutics (NASDAQ:GBT) reported positive data for its sickle cell disease drug, voxelotor.

  • [By Cory Renauer]

    Experimental treatments that use the body’s own immune system to fight cancer are nothing short of amazing. At the year’s biggest scientific conference for cancer drug developers, bluebird bio (NASDAQ:BLUE) showed us that its candidate can prolong the lives of people who had exhausted all available options.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on bluebird bio (BLUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rafi Farber]

    Here’s some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ: CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year by Gilead Sciences Inc. (NASDAQ: GILD).

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

Top 5 Performing Stocks To Buy For 2019

Leave a reply

The Indian benchmark indices are trading on aflatnote this Thursday morning with the Niftyadding3points and is tradingat10,773mark.The Sensex is trading higher by9points at 35,655.

Nifty energy is the outperforming sector with oil & gas stocks gaining the most. The rise in stock prices is mainly aided by fall in global crude oil prices after US President Donald Trump in a tweet to OPEC demanded to reduce oil prices.

BPCL is trading higher by 1.7 percent while HPCL, IOC and ONGC are the other gainers. Reliance Industries ahead of its 41st AGM is up close to 1 percent.

From the auto space Mahindra & Mahindra is up 1 percent but Tata Motors and Tata Motors DVR are trading lower by 2-3 percent.

related news Yes Bank stock rallies 3% after SEBI approves launch of its mutual fund business Biocon shares gain nearly 2% on EU GMP certification for Bengaluru facility Force Motors gains 4% post June sales data

Bank Nifty has managed to stay in the green by the skin of its teeth with gains from Yes Bank which jumped 2 percent followed by Kotak Mahindra Bank and IndusInd Bank.

Top 5 Performing Stocks To Buy For 2019: Royal Dutch Shell PLC(RDS.A)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Royal Dutch Shell plc ADR Class A (RDS.A)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    Much of Wall Street will tell you to stick with the oil industry giants – companies like Exxon Mobil Corp. (NYSE: XOM) or Royal Dutch Shell Plc. (NYSE: RDS.A).

  • [By Ethan Ryder]

    Royal Dutch Shell plc ADR Class A (NYSE: RDS.A) and Jagged Peak Energy (NYSE:JAG) are both oils/energy companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Royal Dutch Shell plc ADR Class A (RDS.A)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Buy For 2019: Nortek Inc.(NTK)

Advisors’ Opinion:

  • [By Logan Wallace]

    News coverage about Nortek (NASDAQ:NTK) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nortek earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the construction company an impact score of 47.1103071190091 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 5 Performing Stocks To Buy For 2019: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Earnings season is well underway. And if you’re looking to make real money, the time to get started is now.Money MorningQuantitative Specialist Chris Johnson argues the markets are at a tipping point. And with just a few smart plays in today’s classic stock picker’s market… you can pull in triple-digit gains with just a small investment.Read those picks right here.

    The Top Stock Market Stories for Friday
    General Electric Co. (NYSE: GE) leads the earnings calendar as reporting for the second quarter moves into full swing. The Boston-based conglomerate is expected to report earnings per share (EPS) of $0.18 on top of $29.76 billion in revenue. Former Dallas Federal Reserve Bank Vice President Jerry O’Driscoll offered some choice words for the U.S. central bank. In an interview with CNBC, O’Driscoll warned that the Fed is being “very aggressive” with interest rate policy in 2018. He warned the central bank is ignoring important factors like a rising dollar and the flattening yield curve. The former bank executive argued that he doesn’t see the case for additional rate hikes in the year ahead. This is one reason why investors should protect themselves from any downside caused by the Fed. According toThe Wall Street Journal, three top cybersecurity officials are departing their positions at the FBI. The departures are planned due to their ongoing concerns about cybersecurity attacks from abroad and disagreements with the Trump administration.
    Three Stocks to Watch Today: MSFT, SKX, SNA
    Shares of Microsoft Corp.(Nasdaq: MSFT) popped more than 3.2% after the cloud computing and software giant topped earnings expectations after the bell Thursday. The company topped $100 billion for its fiscal 2018. This is the first time that it has ever reached this revenue level for a year. The firm reported EPS of $1.13, topping Wall Street estimates by $0.05. The firm reported revenue of $30.09 billion, besting expectations of $29.21 billion. Shares of Snap-on

  • [By Rich Smith]

    Has there ever been a more surprising turnaround story than Cleveland-Cliffs (NYSE:CLF)?

    Once a bifurcated coal and iron miner known as Cliffs Natural Resources, folks began writing Cleveland-Cliffs’ obituary in 2012 after President Obama was elected to his second term — an apparent death knell to anyone involved in the coal industry. Three years later, the predictions seemed to be coming true, and analysts opined about whether Cleveland-Cliffs could even survive to the end of Obama’s term. Within only a few short months, the stock would bottom out. But fast-forward a few years years, and what do we see today?

  • [By Brian Feroldi, Keith Speights, and Neha Chamaria]

    With that in mind, we asked a team of Motley Fool investors to highlight a stock that was recently purchased by a well-known investor.Here’s why they called outCleveland-Cliffs (NYSE:CLF), Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL), andSiteOne Landscape Supply (NYSE:SITE).

  • [By Jeremy Bowman, Rich Smith, and Tyler Crowe]

    However, understanding Wall Street’s blind spots also presents an opportunity for retail investors. The experts tend to focus too much on the short term, obsessing over quarterly earnings rather than the big picture. Other times, Wall Street gives up on a stock earlier only to see that sleeper turn into a big winner. Keep reading to see why our Motley Fool investors thinkCleveland-Cliffs, Inc.(NYSE:CLF),Loma Negra(NYSE:LOMA), andSodaStream International(NASDAQ:SODA) may be just these kinds of stocks with big potential.

  • [By Stephan Byrd]

    Hudbay Minerals (NYSE: HBM) and Cleveland-Cliffs (NYSE:CLF) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Top 5 Performing Stocks To Buy For 2019: Schwab US Large-Cap ETF (SCHX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Milestone Group Inc. decreased its stake in Schwab US Large-Cap ETF (NYSEARCA:SCHX) by 4.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,425 shares of the company’s stock after selling 2,710 shares during the period. Schwab US Large-Cap ETF makes up 0.7% of Milestone Group Inc.’s investment portfolio, making the stock its 19th largest holding. Milestone Group Inc.’s holdings in Schwab US Large-Cap ETF were worth $4,001,000 as of its most recent filing with the Securities & Exchange Commission.

Top 5 Performing Stocks To Buy For 2019: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BIOLINERX Ltd/S (BLRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    BioLine Rx Ltd.(Nasdaq: BLRX) has the cheapest share price of the three stocks on this list.

    Currently trading at $1.16 per share, this Israel-based company focuses on developing therapeutics for a range of medical needs, including serious cardiac issues, liver fibrosis, pain management, cancer, and inflammatory bowel disease.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top Heal Care Stocks To Invest In 2018

Leave a reply

The natural gas and solar sectors will survive and maybe even thrive in the wake of President Donald Trumps decision last week to withdraw from the Paris climate accord.

Trump said Thursday that the U.S. will leave the Paris accord because it is very unfair, at the highest level, to the United States. Staying in the agreement would pose serious obstacles for the U.S. as it begins the process of unlocking the restrictions on Americas abundant energy reserves, he said.

Top Heal Care Stocks To Invest In 2018: PetSmart Inc(PETM)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products now roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) is well below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been the best performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) isstill below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been much stronger performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

Top Heal Care Stocks To Invest In 2018: Zions Bancorporation(ZION)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    In the super-regional banks that are not money center banks, Regions Financial Corp. (NYSE: RF) was up 6.3% at $13.22, and Zions Bancorporation (NASDAQ: ZION) was last seen up 3.8% at $38.30. They would both do better with lower regulatory costs and be able to better compete against larger banks when their stress test results had not been as strong.

  • [By Nelson Hem]

    See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).

Top Heal Care Stocks To Invest In 2018: Matrix Service Company(MTRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Matrix Service Co (NASDAQ: MTRX) shares were also up, gaining 16 percent to $18.58 as the company posted better-than-expected Q4 results.

    Equities Trading DOWN

Top Heal Care Stocks To Invest In 2018: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By William Romov]

    Currently trading at $1.09 per share, BioLine Rx Ltd. (Nasdaq: BLRX) develops a broad range of drug candidates to treat cancer, liver fibrosis, and even dry eye syndrome.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:

Top Heal Care Stocks To Invest In 2018: Panera Bread Company(PNRA)

Advisors’ Opinion:

  • [By Seth McNew]

    Other companies have followed suit with great success, including PaneraBread (NASDAQ:PNRA), which has focused on improving the customer experience, including via shorter wait times. Panera 2.0 was largely successful because of the company’s focus on its digital strategy and Chipotle looks to be doing the same thing.

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

  • [By Lisa Levin]

    Shares of Panera Bread Co (NASDAQ: PNRA) got a boost, shooting up 14 percent to $312.29 after the company agreed to be acquired by JAB for $7.5 billion.

Hot Medical Stocks To Own For 2018

Leave a reply

Cell Medx Corp (OTCBB: CMXC) is in the news for insider trading. Reading a headline with insider trading generally sends chills, especially if you are the part of the management team of said company. But lets consider for a moment that this could be a buy opportunity, or at least an event worthy of shining the spotlight on a small(ish) bio-tech firm.

Cell Medx Corp (OTCBB: CMXC) is an early stage bio-tech firm focusing on the discovery, development and commercialization of therapeutic products. With treatments for diabetes, Parkinsons Disease and high blood pressure in their wheelhouse, Cell Medx is plugged into three of the most significant medical conditions that affect the population.

The company recently announced it had completed the registration process with the FDA, and that it is conducting ongoing clinical trials for a diabetes therapy. According to their most recent financials, they eliminated over $800k of liabilities from their balance sheet, and they have a strong cash reserve, indicators that they are well positioned for reverse mergers or acquisition by a larger, more established company.

Hot Medical Stocks To Own For 2018: Nuveen Select Tax Free Income Portfolio(NXP)

Advisors’ Opinion:

  • [By Eric Volkman]

    Income investors might be wary of Qualcomm, as the company loves to spend its money — at times, its dividend payouts and share buybacks have exceeded free cash flow. Compounding that matter, the company should soon close the door on its acquisition of European peer NXP Semiconductor (NYSE:NXP), a deal with an estimated enterprise value of $47 billion.

Hot Medical Stocks To Own For 2018: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Matthew Briar]

    There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.

    It’s yet another reason for RTI investors to be enthused.

    Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.

    The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.

    The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.

    The company’

  • [By Matthew Briar]

    Although the past several years have been very good ones for the cannabis — marijuana and hemp — industry, it’s still mostly being done in an old, artisan-style fashion. Most companies haven’t figured out a way of scaling up their outputs by improving their operating/production efficiency, even though the market’s growth has merited. Radient Technologies Inc (CVE:RTI) represents that next evolution of the cannabinoid business, introducing a new approach to extracting cannabinoids from cannabis plants that will not only improve yields, but create a superior, purer product.

    Canada-based Radient Technologies has developed — and patented – an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along. To fully appreciate why it matters, however, one has look at the approach other ingredients suppliers are utilizing now.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated to 50 degrees Celsius (or more), and over the course of several hours, the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s hardly ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, a lot of things you don’t want to extract can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies’ microwave assisted processing changes all of this.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

  • [By Matthew Briar]

    At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”

    It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.

    No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”

    Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho

  • [By James E. Brumley]

    Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

    Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

    And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

    It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

    It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

    In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

    It’s a rather amazing science, really. Radient Technologies uses an ingredient-extraction process called microwave assisted proc

Hot Medical Stocks To Own For 2018: Federal-Mogul Holdings Corporation(FDML)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Mario Gabelli on Monday gained the upper hand in his battle to force Carl Icahn to sweeten his offer for a car-parts manufacturer. Icahn, who owns 82 percent of Federal-Mogul (NASDAQ: FDML), offered $9.25 a share for the remaining stake but fell way short after Gamco Investors boss Gabelli — who has a leading stake in Federal-Mogul — pressed for a higher price.

Hot Medical Stocks To Own For 2018: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By William Romov]

    Currently trading at $1.09 per share, BioLine Rx Ltd. (Nasdaq: BLRX) develops a broad range of drug candidates to treat cancer, liver fibrosis, and even dry eye syndrome.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:

Hot Medical Stocks To Own For 2018: Brown & Brown, Inc.(BRO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    BMO also upgraded Arch Capital Group (ACGL), Brown & Brown (BRO), and Travelers (TRV).

    Shares of American International Group have declined 0.4% to $65.60 at 3:36 p.m. today, whileArch Capital Group has gained 2% to $87.90,Brown & Brown has advanced 0.5% to $44.65, andTravelers has risen 1.3% to $120.79.

Hot Medical Stocks To Own For 2018: 3D Systems Corporation(DDD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows ExOne Co along with other small cap 3D printing stocks like3D Systems Corporation (NYSE: DDD), Stratasys, Ltd (NASDAQ: SSYS) and Voxeljet AG (NYSE: VJET) all peaking in 2013/2014 with the bubble clearly bursting since then:

  • [By Jack Delaney]

    Here are 10 virtual reality stocks to watch in 2017, with today’s opening price (Feb. 22) and the year-to-date (YTD) return thus far:

    3D Systems Corp. (NYSE: DDD); $17.12; +26.71% YTDUniversal Display Corp. (Nasdaq: OLED); $71.60; +25.49% YTDAdvanced Micro Devices Inc. (Nasdaq: AMD); $14.30; +24.22% YTDFacebook Inc. (Nasdaq: FB); $133.60; +18.64% YTDAdobe Systems Inc. (Nasdaq: ADBE); $119.67; +15.93% YTDSony Corp. (NYSE ADR: SNE); $31.29; +11.49% YTDAlphabet Inc. (Nasdaq: GOOGL); $848; +7.49% YTDAmbarella Inc. (Nasdaq: AMBA); $57.85; +6.26% YTDMicrosoft Corp. (Nasdaq: MSFT); $64.33; +3.16% YTDRockwell Collins Inc. (NYSE: COL); $93.97; +0.97% YTD

    The virtual reality industry could reach $33.9 billion in value by 2022, which is why virtual reality stocks are more popular than ever.

  • [By Beth McKenna]

    While Stratasys’ stock is still down significantly from its all-time high, it’s showing signs of life this year. It’s gained 17% in 2017, through March 3, outpacing rival 3D Systems’ (NYSE:DDD)9.3% gain and the S&P 500’s total return of 6.9%. Shares of 3D Systems had been riding higher in 2017, through plummeted 10% after the company announced earnings on Feb. 28. Quarterly revenue and 2017 revenue guidance came in lighter than Wall Street analysts were expecting.

day trading penny stocks

Leave a reply

15 Most Overlooked Tax Deductions: 2017

For Fiduciary Rule, Morningstar Sees Up to $150M in Annual Class Action Settlements

Top 10 Cities for Millennial Homebuyers

Wells Fargo & Co. said credit-card applications dropped 55 percent in February from a year earlier, the biggest decline since a scandal involving fake accounts erupted in September.

Retail customers opened 43 percent fewer checking accounts in February, marking the sixth straight month of declines since regulators fined the bank over the creation of unauthorized accounts.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

The service, to be called Intuitive Investor, aims to bring in new, younger clients to its wealth management unit.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources 5 Steps to Eradicate Text Messaging Risk

In this White Paper, we share five steps to help you build a risk management program that enables the benefits of text messaging while protecting…

day trading penny stocks: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:

  • [By William Romov]

    Currently trading at $1.09 per share, BioLine Rx Ltd. (Nasdaq: BLRX) develops a broad range of drug candidates to treat cancer, liver fibrosis, and even dry eye syndrome.

day trading penny stocks: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

day trading penny stocks: Bill Barrett Corporation(BBG)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Petroleo Brasileiro S.A.- Petrobras (NYSE: PBR): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    Northern Oil and Gas, Inc. (AMEX:NOG): Free Stock Analysis Report
     
    Rice Midstream Partners LP (NYSE: RMP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Canadian Natural Resources Limited (NYSE: CNQ): Free Stock Analysis Report
     
    Cenovus Energy Inc (NYSE: CVE): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    ConocoPhillips (NYSE: COP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Lisa Levin]

    On Thursday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Halcon Resources Corp (NYSE: HK) and Bill Barrett Corporation (NYSE: BBG).

day trading penny stocks: PNC Financial Services Group, Inc. (The)(PNC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who is “the market” and how does it “want” to go down? Where’s the commandment that says stocks have to go lower? Who decides that today people who own stocks are by and large going to lose money? And why, of all things, does the market not want to go higher? Didn’t the CEO of the biggest bank, JPMorgan (JPM) , say things are great? Didn’t Wells Fargo (WFC) , after all of that scandal, still show some growth, a sign that it is putting the rough patch behind it? Didn’t Citigroup (C) have its best quarter in years? Wasn’t PNC Financial (PNC) even better, clear triumphs on every single line item? The word “perfect” comes to mind, as in Perfect National Corp. (Wells Fargo and Citigroup are part of TheStreet’s Action Alerts PLUS portfolio.)

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

day trading penny stocks: Silicom Ltd(SILC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Silicom Ltd. (NASDAQ: SILC) shares were also up, gaining 17 percent to $45.45. Silicom reported a major new design win with $17 million in purchase orders.